Lihua Li Selected Research

dehydroandrographolide

1/2019	Dehydroandrographolide Inhibits Osteosarcoma Cell Growth and Metastasis by Targeting SATB2-mediated EMT.
10/2017	Protective effect of dehydroandrographolide on obstructive cholestasis in bile duct-ligated mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lihua Li Research Topics

Disease

73	Neoplasms (Cancer) 01/2022 - 10/2004
31	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2008
13	Inflammation (Inflammations) 05/2022 - 06/2006
13	Infections 01/2022 - 01/2005
10	Atherosclerosis 05/2022 - 04/2014
10	Osteosarcoma (Osteogenic Sarcoma) 02/2020 - 01/2012
8	Hepatocellular Carcinoma (Hepatoma) 12/2020 - 08/2011
8	Hypoxia (Hypoxemia) 07/2019 - 11/2007
7	Glioma (Gliomas) 01/2022 - 11/2011
7	Neoplasm Metastasis (Metastasis) 12/2021 - 06/2015
6	Atherosclerotic Plaque (Atheroma) 05/2022 - 01/2016
6	Wounds and Injuries (Trauma) 05/2022 - 12/2019
6	Fibrosis (Cirrhosis) 01/2022 - 11/2012
6	Vascular Calcification 03/2021 - 01/2016
6	Carcinoma (Carcinomatosis) 11/2019 - 03/2012
6	Carcinogenesis 01/2019 - 01/2013
5	Ovarian Neoplasms (Ovarian Cancer) 02/2016 - 01/2005
4	Bacterial Infections (Bacterial Infection) 05/2022 - 01/2018
4	Parkinson Disease (Parkinson's Disease) 02/2022 - 10/2008
4	Colorectal Neoplasms (Colorectal Cancer) 05/2018 - 09/2007
4	Ischemia 01/2014 - 03/2008
3	Body Weight (Weight, Body) 01/2022 - 01/2018
3	Rheumatoid Arthritis 01/2022 - 05/2013
3	Heart Failure 10/2021 - 01/2009
3	Hemorrhage 07/2021 - 12/2013
3	Delirium 01/2021 - 01/2017
3	Hypertension (High Blood Pressure) 01/2021 - 01/2009
3	Diabetic Foot 01/2020 - 07/2017
3	Stroke (Strokes) 10/2019 - 08/2006
3	Obesity 01/2019 - 08/2015
3	Squamous Cell Carcinoma of Head and Neck 01/2019 - 01/2013
3	Colonic Neoplasms (Colon Cancer) 06/2015 - 12/2010
3	Prostatic Neoplasms (Prostate Cancer) 01/2015 - 01/2008
2	Chronobiology Disorders (Circadian Rhythm Disorder) 10/2022 - 01/2022
2	Wound Infection (Wound Infections) 03/2022 - 01/2022
2	Allergic Rhinitis 03/2022 - 04/2018
2	Dementia (Dementias) 01/2022 - 10/2019
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 08/2015
2	Weight Gain 01/2022 - 05/2014

Drug/Important Bio-Agent (IBA)

23	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2011
16	Proteins (Proteins, Gene)FDA Link 10/2021 - 10/2004
15	Biological ProductsIBA 01/2022 - 01/2008
14	Pharmaceutical PreparationsIBA 01/2022 - 01/2005
12	MicroRNAs (MicroRNA)IBA 12/2020 - 12/2010
9	CytokinesIBA 10/2022 - 05/2011
8	LipidsIBA 10/2022 - 08/2013
8	Long Noncoding RNAIBA 12/2020 - 09/2015
8	Messenger RNA (mRNA)IBA 06/2020 - 12/2010
7	CopperIBA 01/2022 - 06/2008
6	HydrogelsIBA 05/2022 - 12/2019
6	Phenobarbital (Luminal)FDA Link 01/2022 - 01/2017
6	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 09/2007
6	ChitosanIBA 10/2021 - 01/2016
6	BismuthIBA 01/2021 - 01/2018
5	Peptides (Polypeptides)IBA 01/2022 - 08/2009
5	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2021 - 10/2016
5	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2020
5	Oxygen (Dioxygen)IBA 01/2021 - 11/2007
5	Anti-Bacterial Agents (Antibiotics)IBA 11/2019 - 01/2005
4	Apolipoproteins E (ApoE)IBA 05/2022 - 05/2016
4	Silicon Dioxide (Silica)FDA LinkGeneric 05/2022 - 01/2018
4	Estrogen ReceptorsIBA 01/2022 - 08/2009
4	EnzymesIBA 01/2022 - 01/2013
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 01/2017
3	oxidized low density lipoproteinIBA 05/2022 - 01/2018
3	Indicators and Reagents (Reagents)IBA 01/2022 - 03/2012
3	LipopolysaccharidesIBA 01/2022 - 01/2021
3	Biocompatible Materials (Biomaterials)IBA 12/2021 - 10/2016
3	Blood Glucose (Blood Sugar)IBA 02/2021 - 08/2013
3	Dinoprostone (PGE2)FDA Link 01/2021 - 01/2018
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 05/2014
3	Galectin 3 (LGALS3)IBA 01/2021 - 04/2019
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 06/2020 - 01/2019
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 02/2020 - 10/2016
3	Advanced Glycation End ProductsIBA 01/2020 - 12/2006
3	Phosphotransferases (Kinase)IBA 07/2019 - 03/2008
3	thiamine triphosphorate (TTP)IBA 01/2018 - 01/2015
3	IonsIBA 09/2017 - 10/2016
3	isoalantolactoneIBA 02/2016 - 01/2013
3	PlatinumIBA 02/2007 - 01/2005
2	CholesterolIBA 05/2022 - 01/2018
2	OsteopontinIBA 05/2022 - 06/2021
2	CarbonIBA 01/2022 - 01/2018
2	SmokeIBA 01/2022 - 05/2018
2	human ERBB2 proteinIBA 01/2022 - 05/2019
2	MethyltransferasesIBA 01/2022 - 11/2011
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022 - 01/2022
2	InterleukinsIBA 12/2021 - 08/2017
2	Hematoxylin (Haematoxylon)IBA 06/2021 - 01/2020

Therapy/Procedure

27	Therapeutics 05/2022 - 01/2005
9	Drug Therapy (Chemotherapy) 01/2022 - 01/2005
6	Photochemotherapy (Photodynamic Therapy) 10/2021 - 10/2016
5	Photothermal Therapy 01/2022 - 09/2017
4	Precision Medicine 02/2020 - 01/2018
4	Surgical Amputation (Amputations) 01/2020 - 01/2016
3	Neoadjuvant Therapy 01/2022 - 09/2017
3	Radiotherapy 03/2018 - 11/2011
3	Plasma Exchange 01/2016 - 01/2015
2	Immunotherapy 12/2021 - 08/2017
2	Injections 10/2021 - 04/2020